Collagenase clostridium histolyticum is under clinical development by Endo International and currently in Phase III for Unspecified Musculoskeletal Disorders.
PNAS: New drug therapy for Clostridium difficile infection is expected to be developed Not only fever but also sensory loss is an early symptom of COVID-19 patients The price of parts increased by 13 ...
PNAS: New drug therapy for Clostridium difficile infection is expected to be developed The price of this equipment has increased by 250,000 yuan every hour. Today, Nature reveals the mystery of stem c ...
INR:3861. rummy video game The first generic version of Zhengda Tianqing Emtricitabine and Tenofovir Tablets for the treatment of AIDS was approved! "Pharmaceuti ...